Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drake D Duane

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.
Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future ResearchEdward Justin Modestino, Kenneth Blum, Marlene Oscar-Berman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2005
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyDaniel Truong, Drake D Duane, Joseph Jankovic, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.
Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future ResearchEdward Justin Modestino, Kenneth Blum, Marlene Oscar-Berman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2005
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyDaniel Truong, Drake D Duane, Joseph Jankovic, et al.
Pageof 1